Yahoo
    NasdaqGS - Nasdaq Real Time Price USD

    SpyGlass Pharma, Inc. (SGP)

    34.45 +0.81 (+2.41%)
    At close: 4:00:00 PM EST
    34.45 0.00 (0.00%)
    After hours: 4:00:10 PM EST
    Loading Chart for SGP
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System

    SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System
    GlobeNewswire 15d ago
    SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability

    SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability
    GlobeNewswire 1mo ago
    SpyGlass Pharma to Participate in Upcoming Investor Conferences

    SpyGlass Pharma to Participate in Upcoming Investor Conferences
    GlobeNewswire 2mo ago
    SpyGlass Pharma Celebrates Grand Opening of New Irvine Headquarters, Positioning Itself for First Product Launch and Custom R&D Space

    SpyGlass Pharma Celebrates Grand Opening of New Irvine Headquarters, Positioning Itself for First Product Launch and Custom R&D Space
    PR Newswire 2mo ago
    SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing

    SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing
    GlobeNewswire 4mo ago
    SpyGlass Pharma to Participate in Upcoming Investor Conferences

    SpyGlass Pharma to Participate in Upcoming Investor Conferences
    GlobeNewswire 5mo ago
    SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System

    SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System
    GlobeNewswire 5mo ago
    SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

    SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
    GlobeNewswire 5mo ago
    SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update

    SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update
    GlobeNewswire 7mo ago
    SpyGlass Pharma (SGP) Reports Positive 4 Year Glaucoma Trial Results

    SpyGlass Pharma (SGP) Reports Positive 4 Year Glaucoma Trial Results
    Simply Wall St. 3d ago
    SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

    SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
    GlobeNewswire 2mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: